Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

Completed

Conditions studied: Achondroplasia

In brief

This is a long-term, multi-center, observational study in children 2.5 to \<17 years with achondroplasia (ACH). The objective is to evaluate growth, ACH-related medical complications, assessments of health-related quality of life, body pain, functional abilities, cognitive functions, and treatments of study participants. No study medication will be administered.

Key facts

Study ID
NCT04035811
Run by
QED Therapeutics, a BridgeBio company
People needed
271
Starts
2019-08-12
Expected to finish
2025-08-27
Last updated by the study team
2026-04-03

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.